Literature DB >> 7038925

An evaluation of co-trimoxazole in the treatment of Plasmodium falciparum malaria.

C F Hansford, J Hoyland.   

Abstract

Two dosage schedules of co-trimoxazole, the standard antibacterial and a 2-day high-dose schedule, were compared with a standard course of chloroquine in the treatment of uncomplicated Plasmodium falciparum malaria. Parasites were cleared from the blood at similar rates, but pyrexia responded more slowly following the standard cotrimoxazole dose. No recrudescences were detected in those observed for up to 60 days after treatment.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7038925

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  HIV treatments have malaria gametocyte killing and transmission blocking activity.

Authors:  Charlotte V Hobbs; Takeshi Q Tanaka; Olga Muratova; Jillian Van Vliet; William Borkowsky; Kim C Williamson; Patrick E Duffy
Journal:  J Infect Dis       Date:  2013-03-28       Impact factor: 5.226

Review 2.  Malaria prophylaxis in travellers: the current position.

Authors:  D Stürchler
Journal:  Experientia       Date:  1984-12-15

Review 3.  HIV-1 Impact on Malaria Transmission: A Complex and Relevant Global Health Concern.

Authors:  Ashleigh Roberds; Emily Ferraro; Shirley Luckhart; V Ann Stewart
Journal:  Front Cell Infect Microbiol       Date:  2021-04-12       Impact factor: 5.293

Review 4.  Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review.

Authors:  Christine Manyando; Eric M Njunju; Umberto D'Alessandro; Jean-Pierre Van Geertruyden
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.